Global High-Priority Regulatory Events — June 12, 2026

12-06-2026

BioRestorative Therapies, Inc. entered into a $1,000,000 revolving loan agreement with Bowery Group LLC on June 10, 2026, bearing 12% annual interest (16% default rate), with proceeds for general corporate purposes. Concurrently, three directors (Francisco Silva, Nickolay Kukekov, Patrick F. Williams) resigned effective June 11, 2026, and three new directors designated by the lender (Mika Grasso, Katharyn Field, Jatinder Dhaliwal) were appointed on June 12, 2026. The board changes reflect lender influence under the agreement, while Chairman Lance Alstodt and director David Rosa remain.

• · The revolving loan matures one year from the closing of each loan, with optional prepayment and reborrowing allowed.
• · No loans may be requested after the tenth business day preceding the Maturity Date.
• · Mika Grasso (age 28) is an Investment Director at a family office; Katharyn Field (age 43) is CEO of iSpecimen Inc.; Jatinder Dhaliwal (age 38) is a registered pharmacist and CEO/director of multiple public companies.
• · All three new directors are deemed independent under Nasdaq standards; Mr. Grasso qualifies as an audit committee financial expert.
• · The new directors will receive standard non-employee director compensation.
• · No family relationships or material interests in transactions requiring disclosure under Item 404(a) exist between the new directors and the company's officers/directors.

12-06-2026

Lument Finance Trust, Inc. held its annual meeting on June 10, 2026, re-electing all six director nominees and approving executive compensation and KPMG as auditor for FY2026. Subsequently, the company declared a $0.04 per share common stock dividend and a $0.4921875 per share preferred stock dividend. Notably, broker non-votes amounted to 8,856,686 shares across director elections and compensation proposals, indicating significant passive holder positions; the KPMG ratification received strong support (42,151,558 for) with only 1,302,421 against, showing nearly no dissent.

• · All six director nominees were elected: James P. Flynn (33,309,017 for), James C. Hunt (33,257,918 for), Neil A. Cummins (30,701,317 for), William A. Houlihan (31,498,256 for), Walter C. Keenan (31,469,825 for), Marie D. Reynolds (33,297,004 for).
• · Advisory compensation approval passed with 30,819,599 for vs. 3,781,895 against and 319,335 abstentions.
• · KPMG ratification passed overwhelmingly: 42,151,558 for, 1,302,421 against, 323,536 abstentions.
• · Broker non-votes were 8,856,686 for each director election and compensation vote.
• · Common stock dividend: $0.04 per share; Preferred stock dividend: $0.4921875 per share (7.875% Series A).

12-06-2026

Warby Parker Inc. held its Annual Meeting of Stockholders on June 8, 2026, with approximately 95.97% of combined voting power represented. Stockholders elected three Class II directors (Dave Gilboa, Youngme Moon, and Ronald Williams), ratified Ernst & Young LLP as independent auditor for fiscal year 2026, and approved on an advisory basis the compensation of named executive officers. All proposals passed, though Ronald Williams received a notable 8.5% withhold vote (20,194,053 votes withheld).

• · Record date for voting was April 16, 2026.
• · Class A common stock holders had one vote per share; Class B common stock holders had ten votes per share.
• · Ronald Williams received 217,106,963 votes FOR and 20,194,053 votes WITHHELD (8.5% withhold).
• · Ratification of Ernst & Young LLP passed with 253,376,674 FOR, 141,090 AGAINST, and 20,632 abstentions.
• · Say-on-pay proposal received 227,769,229 FOR, 9,507,845 AGAINST, and 23,942 abstentions.
• · Broker non-votes totaled 16,237,380 on director elections and say-on-pay, but were not applicable on auditor ratification.

12-06-2026

Tianci International, Inc. filed Amendment No. 1 to its S-1 registration statement for an offering of Units and Pre-Funded Units, which will result in the issuance of 20% or more of the company's outstanding common stock. The offering price is to be determined at pricing, and stockholder approval was obtained on April 10, 2026 via written consent from holders of 2,347,615 shares (64.87% of voting power). The company is a Nevada holding company with operations solely in Hong Kong, and it faces significant legal and operational risks related to its Hong Kong base and potential future PRC regulatory actions, though it currently believes it does not require Mainland China approvals for the offering.

• · The offering is expected to be completed within two trading days following commencement of sales, with delivery versus payment/receipt versus payment.
• · No escrow or trust account arrangements have been made for investor funds.
• · The company obtained stockholder approval for Nasdaq Listing Rule 5635(d) on April 10, 2026 via written consent.
• · An Information Statement on Schedule 14C will be filed and mailed to stockholders; actions may not become effective earlier than 20 calendar days after mailing.
• · The company and its subsidiaries have received all requisite permissions from Hong Kong authorities to operate, including a business registration certificate, and are not required to obtain permissions from Hong Kong authorities to issue securities.
• · The company does not have operations in Mainland China, does not own or control any entity there, and has no VIE structure.
• · The company believes it is not subject to CAC cybersecurity review for data security or the offering.
• · Legal counsel confirmed no CSRC or other Mainland China approvals are required for the offering based on six specified factors.
• · The company faces risks from potential changes in PRC-Hong Kong political arrangements, laws, or regulations that could materially affect operations or the value of securities.

12-06-2026

Evanston Multi-Alpha Fund is seeking shareholder approval for a transaction where XA Investments LLC (XAI) will become the investment adviser and Evanston Capital Management, LLC (ECM) will become sub-adviser, maintaining the same portfolio management team and investment strategy. The proposals include a new advisory agreement, a new sub-advisory agreement, election of a new six-member board of trustees, and conversion from a tender offer fund to an interval fund with quarterly repurchase offers. The current board unanimously recommends voting in favor of all proposals, citing benefits such as access to XAI's resources, continuity of management, and potential for asset growth and economies of scale.

• · Proposals 1, 2, and 3 are interdependent; if any fails, none will be implemented.
• · Proposal 4 (interval fund conversion) is independent; if approved, conversion will occur within 15 months after shareholder approval.
• · The advisory fee under the New Advisory Agreement will be calculated on average daily net assets (instead of month-end net assets) if the Fund converts to an interval fund, but ECM and XAI do not expect a material change in fee amounts.
• · The Fund currently provides liquidity via quarterly tender offers of 5-25% of outstanding shares under Rule 13e-4.
• · The special meeting is scheduled for August 13, 2026 at 10:00 a.m. Central Time.
• · Proxy cards must be received by 11:59 p.m. Eastern Time on August 12, 2026.

12-06-2026

FutureCorp Space Acquisition 1, a blank-check SPAC, filed an 8-K on June 12, 2026, reporting the closing of its initial public offering (IPO) and a simultaneous private placement on June 9, 2026. The company raised gross proceeds of $230,000,000 from the IPO of 23,000,000 units at $10.00 per unit (including full exercise of the underwriters' over-allotment option) and $6,000,000 from the sale of 6,000,000 private placement warrants at $1.00 each, bringing total trust account proceeds to $230,000,000. The filing includes an audited balance sheet as of June 8, 2026, and notes that the company has not yet commenced operations or selected a business combination target.

• · The company is incorporated in the Cayman Islands and has a fiscal year end of December 31.
• · Transaction costs of $14,498,434 were incurred, including $4M cash underwriting fee, $9.8M deferred underwriting fee, and $698,434 in other offering costs.
• · The company has an accumulated deficit of $8,617,340 and a total shareholders' deficit of $8,616,765.
• · Auditor is WithumSmith+Brown, PC, engaged since 2026.
• · The Business Combination must involve a target with a fair market value of at least 80% of the net trust account balance at signing.
• · Trust proceeds are initially invested in U.S. government treasury obligations or money market funds meeting Rule 2a-7 conditions; the company may later convert to cash in a demand deposit account to mitigate investment company risk.

12-06-2026

12-06-2026

Asian Energy Services Limited (AESL) held an equity shareholders meeting on June 12, 2026, to approve the Scheme of Merger by Absorption of Oilmax Energy Private Limited (OEPL) into AESL, as directed by the National Company Law Tribunal (NCLT) Mumbai Bench. The meeting was conducted via video conferencing and was chaired by Mr. Mukesh Mittal, IRS (Retd.), with the proposed share exchange ratio set at 117 fully paid-up equity shares of ₹10 each of AESL for every 10 fully paid-up equity shares of ₹10 each of OEPL. The e-voting results and scrutinizer's report are to be communicated to stock exchanges within two working days.

• · The meeting was convened pursuant to NCLT Mumbai Bench order dated April 22, 2026, in Company Scheme Application No. C.A. (CAA) No. 49(MB)/2026.
• · The meeting was held via Video Conferencing/Other Audio Video Means (VC/OAVM) and lasted from 11:00 AM to 11:23 AM IST.
• · The notice of the meeting was sent to all equity shareholders as of the cut-off date of May 1, 2026, and published in 'Business Standard' (English) and 'Navshakti' (Marathi).
• · The resolution seeks approval under Sections 230 to 232 read with Section 66 of the Companies Act, 2013.
• · E-voting results and the Scrutinizer's Report will be filed with stock exchanges within two working days and posted on the websites of the Company, NSDL, and the stock exchanges.

12-06-2026

Rocket Pharmaceuticals closed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $180 million in gross proceeds, providing a non-dilutive capital infusion. Before the sale, the company had $144.4 million in cash and investments (as of March 31, 2026), and pro forma liquidity increased to approximately $322.6 million, which is expected to fund operations into Q2 2028. The PRV was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket's gene therapy for severe LAD-I.

• · The PRV was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket's gene therapy for severe leukocyte adhesion deficiency-I (LAD-I).
• · Rocket expects the pro forma cash of ~$322.6 million to fund operations into the second quarter of 2028.
• · Rocket's cardiovascular pipeline includes three clinical stage programs targeting inherited cardiomyopathy subtypes: hypertrophic, arrhythmogenic, and dilated cardiomyopathies, representing more than 100,000 patients in the U.S. and EU.
• · The company describes itself as a fully integrated, commercial-stage biotechnology company.

12-06-2026

C21 Investments Inc. reported revenue of $32.6M for FY 2026, up 8.3% from $30.1M in FY 2025, with gross margin stable at 41.7%. However, the company posted a net loss of $3.2M (improved from a $4.0M loss in FY 2025), weighed down by a $4.6M income tax expense and a $13.4M uncertain tax position liability. Adjusted EBITDA grew 13.4% to $5.5M, but quarterly revenue declined sequentially from $8.6M in Q1 to $7.5M in Q4 FY 2026.

• · The company reported a net loss from continuing operations of $3.2M for FY 2026, compared to a $3.8M loss in FY 2025.
• · Income tax expense increased 11.2% to $4.6M in FY 2026 from $4.2M in FY 2025.
• · Uncertain tax position liability surged 36.0% to $13.4M as of March 31, 2026, up from $9.8M a year earlier.
• · Total liabilities increased 2.3% to $29.0M, while shareholders' equity declined 11.3% to $25.4M.
• · Cash decreased 14.9% to $2.2M as of March 31, 2026, from $2.6M a year earlier.
• · Inventory increased 13.3% to $4.6M as of March 31, 2026, from $4.1M a year earlier.
• · Accounts payable and accrued liabilities decreased 13.4% to $1.9M.
• · Income taxes payable decreased 41.6% to $1.7M.
• · The company issued 100,000,000 subordinate shares with a nominal value of $72 during FY 2026.
• · Share-based compensation decreased 72.1% to $236,779 in FY 2026 from $849,559 in FY 2025.
• · Interest expense decreased 36.2% to $187,241 in FY 2026 from $293,675 in FY 2025.
• · Accretion expense decreased 27.0% to $372,018 in FY 2026 from $509,871 in FY 2025.
• · Net loss from discontinued operations decreased 96.2% to $8,080 in FY 2026 from $212,813 in FY 2025.
• · The company repurchased and cancelled 479,500 common shares during FY 2026.
• · Weighted average basic shares outstanding decreased 1.6% to 117,910,795 in FY 2026 from 119,794,951 in FY 2025.
• · Quarterly revenue declined sequentially from $8.6M in Q1 FY 2026 to $7.5M in Q4 FY 2026.
• · Quarterly Adjusted EBITDA declined sequentially from $2.2M in Q3 FY 2026 to $1.2M in Q4 FY 2026.
• · Quarterly revenue in Q4 FY 2026 ($7.5M) was down 8.1% from Q4 FY 2025 ($8.1M).
• · Quarterly Adjusted EBITDA in Q4 FY 2026 ($1.2M) was down 30.2% from Q4 FY 2025 ($1.7M).
• · Loss from continuing operations in Q4 FY 2026 was $1.4M, slightly improved from $1.5M in Q4 FY 2025.
• · The company had a settlement liability of $1.3M as of March 31, 2026 (current portion $1.2M, non-current $0.1M).
• · Goodwill remained unchanged at $28.5M as of both March 31, 2026 and March 31, 2025.
• · Intangible assets decreased to $6.4M as of March 31, 2026 from $8.1M a year earlier.
• · Right-of-use assets decreased to $8.8M as of March 31, 2026 from $9.4M a year earlier.
• · Property and equipment decreased to $2.3M as of March 31, 2026 from $2.7M a year earlier.
• · The company had a note receivable of $0.8M (current portion) as of March 31, 2026, compared to $0.8M (non-current) a year earlier.
• · Deferred tax asset of $0.1M was recognized as of March 31, 2026, compared to none a year earlier.
• · Derivative liability was reduced to zero as of March 31, 2026 from $27,824 a year earlier.
• · Deferred tax liability was reduced to zero as of March 31, 2026 from $34,817 a year earlier.
• · The company had a commitment to issue shares of $439,443 as of March 31, 2026, down from $628,141 a year earlier.
• · Accumulated other comprehensive loss increased to $2.2M as of March 31, 2026 from $2.1M a year earlier.
• · Deficit increased to $80.1M as of March 31, 2026 from $76.8M a year earlier.

12-06-2026

The Board of Madhav Marbles and Granites Limited, at its meeting on June 12, 2026, approved calling an Extra-Ordinary General Meeting (EGM) scheduled for July 6, 2026 via video conferencing to seek shareholder approval for three material related party transactions. The aggregate outstanding limits sought are INR 50 Crore for Madhav Ashok Ventures Private Limited, INR 40 Crore for Madhav Surfaces (FZC) LLC, and INR 10 Crore for Madhav Natural Stone Surfaces Private Limited. No financial performance data is disclosed, so no positive or negative metrics are available.

• · Board meeting commenced at 3:00 PM and concluded at 4:10 PM on June 12, 2026.
• · EGM will be held on Monday, July 06, 2026 at 11:30 AM IST through Video Conferencing/Other Audio Visual Means.
• · Notice of EGM will be sent via electronic mode to members with registered email addresses and will be available on the company's website.
• · The resolutions are being proposed as Ordinary Resolutions under Regulation 23 of SEBI Listing Regulations and Section 188 of the Companies Act, 2013.
• · Transactions are to be carried out in the ordinary course of business and at arm's length basis or as otherwise permissible.
• · No financial performance data for any period is included in this filing.

12-06-2026

Tino Group Limited, a Cayman Islands company with operations in Hong Kong, filed an F-1 registration statement with the SEC on June 12, 2026, for an initial public offering of Class A ordinary shares. The company has a dual-class share structure where each Class B share carries 20 votes, and Mr. Qin Chen will beneficially own 20,080,400 Class B shares after the offering, giving him majority voting control. The company notes significant regulatory risks from potential Chinese government actions, as all operations are conducted in Hong Kong, a Special Administrative Region of China, and it has no operations or VIE structure in mainland China.

• · The company is an 'emerging growth company' and a 'foreign private issuer' under U.S. securities rules, eligible for reduced disclosure requirements.
• · The offering price per share is not yet determined; the prospectus states an estimated range will be provided.
• · The company intends to list on NYSE American or Nasdaq Capital Market under a symbol not yet specified.
• · There is no restriction on future issuances of Class B shares, which could dilute Class A shareholders.
• · The CSRC's Trial Measures for overseas listings took effect March 31, 2023, requiring domestic companies to file with the CSRC; failure may result in penalties.
• · The company has no operations or VIE structure in mainland China.

12-06-2026

United Community Banks, Inc. (UCB) announced the sale of its equipment finance business, Navitas Credit Corp. and NLFC Reinsurance Corp., to funds managed by Wafra Inc. for $1.9 billion in cash. The transaction is expected to close in Q3 2026 and will result in a one-time pre-tax earnings benefit of $109 million, 3% accretion to tangible book value per share, and 145 basis points of CET1 capital. However, the sale reduces the risk profile by eliminating a segment that accounted for 10% of loans but 50% of net charge-offs, while excess liquidity will be reinvested at lower yields (4.0-4.5%) versus potentially higher loan yields.

• · Navitas had $1.8 billion in owned receivables and 207 employees as of March 31, 2026.
• · United Community Banks had $28.2 billion in assets and 200 offices as of March 31, 2026.
• · The transaction is expected to close in Q3 2026, subject to customary closing conditions.
• · Excess liquidity will be reinvested in lower-risk securities with aggregate weighted average yield between 4.0-4.5% and target duration of less than two years.
• · United intends to evaluate capital deployment alternatives including organic growth, balance sheet optimization, share repurchases, and opportunistic M&A.
• · Navitas' executive leadership team and all employees are expected to remain with the business after the sale.

12-06-2026

12-06-2026

12-06-2026

Indus Fila Ltd reported a net loss of ₹257.40 Lakh for FY2026, widening from a loss of ₹228.88 Lakh in FY2025, with total income falling to ₹5.00 Lakh from ₹16.00 Lakh. The company's net worth remained deeply negative at ₹(1,327.61) Lakh, while total equity and liabilities declined to ₹1,279.48 Lakh from ₹1,506.32 Lakh. The auditor issued a qualified opinion with multiple emphasis-of-matter notes, including the absence of an audit committee, unresolved charges, and the company's suspended listing status as it prepares for relisting.

• · The company's stock is currently suspended from trading on BSE and NSE.
• · The company has not constituted an Audit Committee as required by Section 177 of the Companies Act, 2013.
• · Two charges of ₹3,00,00,000 each (total ₹6,00,00,000) with State Bank of India remain unsatisfied in ROC records, though the company states no such balances exist per NCLT order.
• · A disputed TDS liability of ₹1,75,12,709 from the pre-NCLT period is yet to be resolved with the tax department.
• · The company does not have information on whether its suppliers are registered under the Micro, Small & Medium Enterprises Development Act, 2006.
• · Depreciation on Furniture & Fittings and Computers is not charged as assets are already at residual value.
• · The company's main business is finishing of textile (excluding khadi/handloom); no separate reportable segments.
• · All three directors are designated as Additional Directors; board reconstitution is planned for FY2025-26.
• · The company is not compliant with the Minimum Public Shareholding (MPS) rule of 25% due to suspended listing status.

12-06-2026

TANFAC Industries Ltd. announced that all three resolutions proposed via postal ballot (remote e-voting) were passed with requisite majority by shareholders on May 11, 2026. The resolutions included the appointment of Dr. Ajay Kumar Singh as Non-Executive-Independent Director (special resolution) and the appointment of Dr. L. Ravichandran as Director and Whole-time Director (ordinary resolutions). While promoter and promoter group votes were unanimously in favor (100%), a small fraction of public non-institutional votes (1.81%) opposed the resolutions, though overall approval remained near unanimous at 99.99%.

• · The postal ballot notice was dated May 06, 2026, and the last date of remote e-voting was May 11, 2026.
• · Promoter and promoter group held 10,336,162 shares and voted 100% in favor on all resolutions.
• · Public institutions held 75,634 shares but only 5,253 votes were polled (6.95% participation).
• · Public non-institutions held 9,538,204 shares but only 4,427 votes were polled (0.05% participation).
• · Total outstanding shares of the company are 19,950,000.
• · The voting results and scrutinizer's report are available on the company's website and CDSL's e-voting portal.

12-06-2026

Director Gibson Neil W was awarded 0 Stock Option (Right to Buy).

• · Director Gibson Neil W was awarded 0 Stock Option (Right to Buy)

12-06-2026

Fastenal elected Vishal Talwar as an independent director, effective June 12, 2026, increasing the board from eleven to twelve members. Talwar, currently EVP and Chief Digital & Information Officer at FedEx and President of FedEx DataWorks, brings deep expertise in digital transformation, cybersecurity, and data platforms. He was also appointed to the Nominating and Corporate Governance Committee.

• · Talwar oversees enterprise architecture, cybersecurity, and data platforms at FedEx.
• · He served as Senior Managing Director and Chief Growth Officer for Accenture Technology from April 2015 to August 2025.
• · His previous experience includes Vice President at Wipro (2014-2015), Managing Director at Dell Technologies (2011-2014), Associate Partner at IBM (2006-2011), and senior technology consulting leadership roles from 1996-2006.
• · Talwar will receive a pro-rata portion of the annual retainer and an equity award (payable in cash) per the existing director compensation policy.
• · No arrangements or understandings exist with any person regarding his selection as a director, and no reportable transactions under Item 404(a).

12-06-2026

Xilio Therapeutics held its 2026 annual meeting on June 10, 2026, where stockholders elected four Class II directors (Akintunde Bello, Daniel Curran, Robert Ross, Yuan Xu) and approved the amended and restated 2021 Stock Incentive Plan. Following the meeting, Daniel Curran resigned as a Class II director and was immediately re-appointed as a Class III director to rebalance the board into three equal classes. Stockholders also ratified Ernst & Young LLP as the independent auditor for fiscal 2026.

• · Stockholder votes for Class II directors: Akintunde Bello (3,652,015 for, 130,437 withheld), Daniel Curran (3,709,598 for, 72,854 withheld), Robert Ross (3,719,795 for, 62,657 withheld), Yuan Xu (3,716,549 for, 65,903 withheld); broker non-votes: 1,279,671 for each.
• · Ratification of Ernst & Young LLP: 5,047,290 for, 11,876 against, 2,957 abstaining.
• · Approval of Amended and Restated 2021 Plan: 3,424,710 for, 355,015 against, 2,727 abstaining, 1,279,671 broker non-votes.
• · The Amended and Restated 2021 Plan adds shares underlying outstanding pre-funded warrants to the common share count for calculating the annual evergreen increase.
• · Dr. Curran's compensation arrangements remain unchanged; no compensation due for his resignation and re-appointment.

12-06-2026

Angi Inc. held its Annual Meeting of Stockholders on June 10, 2026, where stockholders elected three Class II directors, approved the amendment and restatement of the 2017 Stock and Annual Incentive Plan, and ratified Ernst & Young LLP as the independent auditor for fiscal 2026. The 2017 Stock Plan was amended to increase the authorized share pool by 2,400,000 shares and extend its term to 2036. Notably, director Glenn H. Schiffman received the lowest support among the director nominees, with approximately 72.1% of votes cast in favor and 27.9% against, indicating significant shareholder dissent.

• · The 2017 Stock Plan term was extended by 10 years to 2036.
• · The plan now includes a minimum vesting requirement, limits on non-employee director compensation, restrictions on share recycling, and default treatment of performance stock units upon change in control.
• · Broker non-votes totaled 4,329,130 shares on the director elections and the stock plan proposal, but zero on the auditor ratification proposal.
• · Glenn H. Schiffman received 20,722,477 FOR votes and 8,014,166 WITHHOLD votes — the lowest support among the three director nominees.

12-06-2026

IEH Corp (IEHC) reported a net loss of $1,296,784 for fiscal year 2026, a sharp reversal from net income of $999,038 in fiscal 2025, as operating income swung from a profit of $574,862 to a loss of $1,631,879. Revenue grew modestly by 2.2% to $29,417,600, but cost of products sold surged 12.0% to $23,866,707, outpacing revenue growth and driving the operating loss. Cash flow from operations turned negative at ($631,130) versus $4,883,619 in the prior year, and cash and cash equivalents declined to $9,647,698 from $10,539,828.

• · Basic loss per share was ($0.53) in FY2026 vs. earnings of $0.42 in FY2025; diluted loss per share was ($0.53) vs. $0.41.
• · Accounts receivable increased 47.0% to $4,719,223 from $3,210,840, while inventories decreased 6.3% to $6,809,722 from $7,265,347.
• · Accounts payable rose 62.6% to $1,426,067 from $876,730.
• · The company took on a new equipment financing line of credit totaling $415,924 (current portion $256,257, non-current $159,667) during FY2026, with no such debt in FY2025.
• · Operating lease right-of-use assets declined 19.3% to $1,588,589 from $1,967,752.
• · Interest income, net decreased 31.3% to $292,349 from $425,291.
• · The company reported a benefit from income taxes of $42,746 in FY2026 vs. a provision of $1,115 in FY2025.
• · Risk factors include global economic slowdown, credit tightening, currency fluctuations, inflationary pressures, regulatory compliance costs, employment cost increases, and ongoing conflicts in Eastern Europe and the Middle East.

12-06-2026

Allied Blenders and Distillers Limited (ABD) published its Annual Report for FY 2025-26, reporting income from operations of ₹3,949 Crore (up 11.5% YoY), highest-ever EBITDA of ₹568 Crore (up 25.8%), and highest-ever PAT of ₹220 Crore (up 13%). The company sold 35.9 million cases (up 8.5%) and highlighted its premiumisation strategy, including launches in super-premium and luxury segments. However, the report notes that some flagship brands sustained momentum while others sparked new conversations, implying mixed brand performance, and the company faces risks from regulatory frameworks and competitive dynamics.

• · ICONiQ White Whisky crossed 10 million cases milestone in March 2026.
• · ICONiQ White sold 5.7 million cases in FY25, emerging as a leading youth-focused brand.
• · Officer's Choice Whisky ranked as the third-largest selling whisky brand globally in 2021.
• · Sterling Reserve Blend 7 became 3rd largest semi-premium whisky in India (FY22).
• · The company commissioned a PET bottling facility at Rangapur, Telangana in September 2025.
• · Completed acquisition of a distillery-cum-bottling facility in Uttar Pradesh from NICOL in January 2026.
• · Acquired Kion Blenders and announced plans to establish a dual-mode distillery in Andhra Pradesh (December 2025).
• · Board approved ~₹525 Crore capex including acquisition of ENA unit in Maharashtra.
• · The company has 40 manufacturing facilities (2 distilleries, 37 bottling units & 1 PET bottle unit).
• · Distribution network reaches over 80,000 retail outlets across 36 countries.
• · Portfolio includes 31 brands across mass premium, prestige, semi-premium, premium and emerging luxury segments.
• · Received 25+ awards and recognitions during the year.
• · ICONiQ White recognized as fastest growing millionaire whisky brand for the 3rd consecutive calendar year in 2025.
• · The report mentions that some flagship brands sustained momentum while others sparked new conversations with emerging consumers, indicating mixed brand performance.
• · The company faces risks from regulatory frameworks and competitive dynamics.

12-06-2026

Marblegate Capital Corp held its 2026 Annual Meeting on June 11, 2026, with 94.5% of outstanding shares represented. Stockholders approved the 2026 Equity Incentive Plan authorizing up to 3,700,000 shares plus an evergreen provision, elected all five director nominees, and ratified Deloitte & Touche as independent auditor. However, the 2026 Plan approval received only 292,663 votes in favor with 845 against and 1,235,796 broker non-votes, indicating relatively low shareholder support relative to total outstanding shares.

• · The 2026 Plan includes an automatic annual increase on the first day of each year from 2027 through 2030 equal to the lesser of 3% of fully diluted shares outstanding or a smaller amount determined by the Board.
• · No incentive stock options may be granted after the 10th anniversary of the Board's adoption of the 2026 Plan.
• · All five director nominees were elected with votes ranging from 68,163,143 to 68,613,143 in favor; Frederick C. Herbst and Meera Joshi received zero withheld votes.
• · Ratification of Deloitte & Touche received 23,575 votes for, 250 against, and 0 abstentions.
• · The proposal to adjourn or postpone the meeting if necessary was approved with 261,416 votes for and 1,007 against.

12-06-2026

Director SYKES JOHN L was awarded 1,173 Restricted Stock Units.

• · Director SYKES JOHN L was awarded 1,173 Restricted Stock Units

12-06-2026

Director FRIEDMAN CATHY was awarded 9,250 Option (right to buy).

• · Director FRIEDMAN CATHY was awarded 9,250 Option (right to buy)

12-06-2026

Director Harrison Suzan F. was awarded 121.266 Stock Units.

• · Director Harrison Suzan F. was awarded 121.266 Stock Units

12-06-2026

Splash Beverage Group filed an S-1 registration statement amid significant financial and operational challenges. The company incurred a net loss of $25.2 million in 2025, its stock price has declined from $0.741 to below $0.20, and it faces imminent NYSE American delisting due to low share price and market capitalization below $5 million. Management is pursuing a potential reverse merger or acquisition in the cannabinoid/wellness sector after a letter of intent with Medterra expired, but no definitive agreement has been reached and the company may lack the time and resources to complete a transaction before delisting.

• · Letter of intent with Medterra expired on May 4, 2026, without a definitive agreement.
• · NYSE American considers $0.10 per share a 'low stock price' triggering immediate delisting; stock traded below $0.20 in late May 2026.
• · Proposed NYSE American rule changes (effective as early as Oct 2026) would increase low-price threshold to $0.25 and add a $5M market cap minimum; stock closed at $0.25 with market cap below $5M as of June 5, 2026.
• · Company may attempt a proportionate reverse stock split (ratio below 1:5) but warns that reverse splits often lead to further price declines.
• · Potential litigation risk from seller of Costa Rican water assets regarding cancellation of Series C Convertible Preferred Stock (issued for $20M deal).
• · Any business combination would result in substantial dilution to existing stockholders.
• · Company has experienced recurring losses and negative cash flows from operations; expects continued losses.
• · No assurance that any acquisition or reverse merger will be completed before NYSE American delisting timeline.
• · Delisting would substantially hinder capital raising ability and could force cessation of operations.

12-06-2026

Mind Medicine (MindMed) Inc. filed an 8-K on June 12, 2026, reporting an officer change under Item 5.02, but the filing does not disclose the specific position, name, or reason for the departure or appointment. The filing also includes Item 5.07 (shareholder vote results) and Item 9.01 (exhibits), but no quantitative financial data, scheduled events, or forward-looking guidance are provided. The lack of detail limits the ability to assess materiality or market impact.

• · Filing date: June 12, 2026
• · AccNo: 0001193125-26-269549
• · File size: 214 KB
• · No specific officer name, title, or reason for change disclosed
• · No financial metrics, guidance, or scheduled events mentioned

12-06-2026

Evolus, Inc. held its Annual Meeting of Stockholders on June 11, 2026, where three proposals were voted upon. Stockholders elected Brady Stewart and Vikram Malik as Class II directors for three-year terms; however, Vikram Malik received a significantly lower number of 'For' votes (21.3M) compared to Brady Stewart (38.5M), with 18.8M withheld votes against Malik, indicating notable shareholder dissent. The ratification of Ernst & Young LLP as independent auditor passed overwhelmingly with 51.2M 'For' votes, and the advisory vote on named executive officer compensation was approved with 39.4M 'For', though 336,958 voted against and 441,629 abstained.

• · The annual meeting date was June 11, 2026; filing date is June 12, 2026.
• · Class II directors elected serve until the 2029 annual meeting or until their successors are elected.
• · Vikram Malik received 18,831,201 withhold votes, representing approximately 46.9% of votes cast (excluding broker non-votes), indicating significant shareholder concern.
• · Broker non-votes totaled 11,183,774 for both the director election and advisory compensation vote.

12-06-2026

12-06-2026

12-06-2026

Edible Garden AG Inc. entered into a Notes Purchase Agreement with Streeterville Capital, LLC on June 12, 2026, issuing a $2.17M unsecured A-1 Note (with $160K OID and $10K expense amount) and a $10M secured B Note, for total gross proceeds of $12M. The B Note is secured by cash in a deposit account and a pledge agreement, with the $10M held at Lakeside Bank under a DACA. The agreement includes a mechanism for exchanging portions of the B Note for additional A Notes as the A Note balance or Series B Preferred Stock value is reduced, but no period-over-period comparisons are available as this is a single-event filing.

• · The A-1 Note carries a $160,000 original issue discount and a $10,000 transaction expense amount, both included in its initial principal balance.
• · The B Note is secured by cash in a deposit account under a DACA and a pledge agreement, with a first-position security interest granted to Investor.
• · Company's obligations under all Notes are guaranteed by three subsidiaries: EDBL Holdings, LLC; 2900 Madison Ave Holdings, LLC; and Edible Garden Corp.
• · Note Exchanges occur automatically on the 61st day if Company does not request them within the 60-day window after a threshold is met.
• · No Note Exchange is permitted if a Trigger Event (as defined in the Notes) has occurred under any Note.
• · The agreement is entered into under Section 4(a)(2) and Rule 506(b) of the Securities Act of 1933.
• · Company represents it is not a shell company and has not had shell company status in the prior 12 months.

12-06-2026

Indian Toners & Developers Ltd. has issued its 36th Annual Report for FY2025-26 and convened the Annual General Meeting (AGM) on July 13, 2026, to adopt audited financials, confirm a final dividend of ₹6.00 per equity share, and seek shareholder approvals for re-appointment of key directors, including Chairman Sushil Jain for three years and Independent Director Sanjay Gupta for a second five-year term. The filing is largely procedural and governance-oriented; the AGM agenda does not highlight any major financial performance changes, but the continued re-appointments indicate board stability.

• · The Register of Members and Share Transfer Books will remain closed from July 10, 2026, to July 12, 2026, for the annual closing.
• · The cut-off date for determining eligibility to vote is July 5, 2026.
• · The company is offering e-voting via NSDL for shareholders, and individual shareholders with demat accounts can vote through their depository accounts.
• · Shri Sushil Jain is proposed to be re-appointed as Wholetime Director (designated Chairman) for three years from August 16, 2026, with remuneration treated as minimum even if profits are inadequate.
• · Shri Satyendra Paroothi is proposed to be re-appointed as Wholetime Director for two years from May 27, 2026.
• · Mr. Sanjay Gupta is proposed to be re-appointed as Independent Director for a second five-year term from June 22, 2026.

12-06-2026

12-06-2026

12-06-2026

Promoter Ramesh Babulal Parekh acquired 25,738 equity shares of Gandhar Oil Refinery (India) Ltd on June 9, 2026 through open market purchase. This increased his holding from 28.67% to 28.69% of the total voting capital. The transaction represents a marginal increase of 0.02% in promoter stake.

• · The acquisition was made through open market purchase on June 9, 2026.
• · The company's total equity share capital is ₹19,57,59,060 consisting of 9,78,79,530 equity shares of face value ₹2 each.
• · The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011.
• · No shares are held in encumbrance (pledge/lien) by the promoter before or after the acquisition.